Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
7.10
+0.01 (0.13%)
At close: Sep 11, 2026, 4:00 PM EDT
7.23
+0.13 (1.85%)
After-hours: Sep 11, 2026, 4:10 PM EDT
Journey Medical Market Cap
Journey Medical has a market cap or net worth of $204.06 million as of September 11, 2026. Its market cap has increased by 7.28% in one year.
Market Cap
204.06M
Enterprise Value
203.96M
1-Year Change
7.28%
Ranking
Category
Stock Price
$7.10
ChartMarket Cap Chart
Since the IPO on November 12, 2021, Journey Medical's market cap has increased from $157.79M to $204.06M, an increase of 29.32%. That is a compound annual growth rate of 5.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 204.06M | -2.46% |
| Dec 31, 2025 | 209.22M | 156.14% |
| Dec 31, 2024 | 81.68M | -23.38% |
| Dec 29, 2023 | 106.61M | 212.54% |
| Dec 30, 2022 | 34.11M | -61.94% |
| Dec 31, 2021 | 89.63M | -43.20% |
| Nov 12, 2021 | 157.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alpha Teknova | 360.25M |
| Emergent BioSolutions | 319.43M |
| Anika Therapeutics | 279.17M |
| Akebia Therapeutics | 263.72M |
| Aurora Cannabis | 241.72M |
| Cardiol Therapeutics | 231.58M |
| SIGA Technologies | 217.70M |
| Organogenesis Holdings | 191.73M |